{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:18:23Z","timestamp":1791224303824,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1080\/00313020701684409","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T15:32:04Z","timestamp":1195227124000},"page":"551-557","source":"Crossref","is-referenced-by-count":44,"title":["Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Amira","family":"Sanki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rooshdiya Z.","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/00313020701684409_bib005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)65277-7","article-title":"p27kip1: a multifunctional cyclin- dependent kinase inhibitor with prognostic significance in human cancers","volume":"154","author":"Lloyd","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1080\/00313020701684409_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I","article-title":"Regulation of the cdk inhibitor p27 and its deregulation in cancer","volume":"183","author":"Slingerland","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1080\/00313020701684409_bib0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.5149","article-title":"p16(MTS-1\/CDKN2\/INK4a) in cancer progression","volume":"264","author":"Rocco","year":"2001","journal-title":"Exp Cell Res"},{"key":"10.1080\/00313020701684409_bib0020","first-page":"1211","article-title":"p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors","volume":"55","author":"Ponce-Castaneda","year":"1995","journal-title":"Cancer Res"},{"key":"10.1080\/00313020701684409_bib0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(00)81237-4","article-title":"Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors","volume":"85","author":"Nakayama","year":"1996","journal-title":"Cell"},{"key":"10.1080\/00313020701684409_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/24179","article-title":"The murine gene p27Kip1 is haplo-insufficient for tumour suppression","volume":"396","author":"Fero","year":"1998","journal-title":"Nature"},{"key":"10.1080\/00313020701684409_bib0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.0303-6987.2004.00243.x","article-title":"Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship","volume":"31","author":"Li","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1080\/00313020701684409_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00000372-199904000-00002","article-title":"Expression of p-27 (kip1) in nevi and melanomas","volume":"21","author":"Morgan","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1080\/00313020701684409_bib0045","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1523-1747.1999.00812.x","article-title":"High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas","volume":"113","author":"Bales","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1080\/00313020701684409_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)65572-1","article-title":"Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival","volume":"153","author":"Florenes","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1080\/00313020701684409_bib0055","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/sj.onc.1201791","article-title":"Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells","volume":"16","author":"Orend","year":"1998","journal-title":"Oncogene"},{"key":"10.1080\/00313020701684409_bib0060","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/sj.onc.1203891","article-title":"Aberrant p27Kip1 promoter methylation in malignant melanoma","volume":"19","author":"Worm","year":"2000","journal-title":"Oncogene"},{"key":"10.1080\/00313020701684409_bib0065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"10.1080\/00313020701684409_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mrfmmm.2004.08.021","article-title":"INK4a\/ARF: a multifunctional tumor suppressor locus","volume":"576","author":"Sharpless","year":"2005","journal-title":"Mutat Res"},{"key":"10.1080\/00313020701684409_bib0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35092592","article-title":"Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis","volume":"413","author":"Sharpless","year":"2001","journal-title":"Nature"},{"key":"10.1080\/00313020701684409_bib0080","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","article-title":"The INK4a\/ARF locus and melanoma","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"10.1080\/00313020701684409_bib0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)70937-5","article-title":"Cutaneous melanoma","volume":"365","author":"Thompson","year":"2005","journal-title":"Lancet"},{"key":"10.1080\/00313020701684409_bib0090","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/sj.onc.1206444","article-title":"Melanoma etiology: where are we?","volume":"22","author":"Tucker","year":"2003","journal-title":"Oncogene"},{"key":"10.1080\/00313020701684409_bib0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H","article-title":"CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas","volume":"25","author":"Holland","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1080\/00313020701684409_bib00100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<255::AID-IJC4>3.0.CO;2-Y","article-title":"Loss of expression of the p16INK4\/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage","volume":"74","author":"Talve","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1080\/00313020701684409_bib00105","first-page":"1845","article-title":"Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma","volume":"6","author":"Straume","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1080\/00313020701684409_bib00110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00008390-200212000-00003","article-title":"Loss of p16 expression is associated with histological features of melanoma invasion","volume":"12","author":"Pavey","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1080\/00313020701684409_bib00115","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","article-title":"Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center","volume":"97","author":"Azzola","year":"2003","journal-title":"Cancer"},{"key":"10.1080\/00313020701684409_bib00120","first-page":"6006","article-title":"Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2\/multiple tumor suppressor gene 1 (CDKN2\/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression","volume":"55","author":"Geradts","year":"1995","journal-title":"Cancer Res"},{"key":"10.1080\/00313020701684409_bib00125","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020701684409_bib00130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000372-199806000-00006","article-title":"p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry","volume":"20","author":"Sparrow","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1080\/00313020701684409_bib00135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<535::AID-IJC10>3.0.CO;2-5","article-title":"Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma","volume":"74","author":"Straume","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1080\/00313020701684409_bib00140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)63110-0","article-title":"Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study","volume":"164","author":"Alonso","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1080\/00313020701684409_bib00145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","article-title":"Cellular senescence in naevi and immortalisation in melanoma: a role for p16?","volume":"95","author":"Gray-Schopfer","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1080\/00313020701684409_bib00150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1600-0560.1998.tb01748.x","article-title":"p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma","volume":"25","author":"Funk","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1080\/00313020701684409_bib00155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/00313020600817951","article-title":"The role of cell cycle regulatory proteins in the pathogenesis of melanoma","volume":"38","author":"Li","year":"2006","journal-title":"Pathology"},{"key":"10.1080\/00313020701684409_bib00160","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"key":"10.1080\/00313020701684409_bib00165","first-page":"43","article-title":"Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells","volume":"21","author":"Zhang","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1080\/00313020701684409_bib00170","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.0303-6987.2005.00389.x","article-title":"Markers of high-risk cutaneous melanoma: is there a winning combination for individualized prognosis?","volume":"32","author":"Carlson","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1080\/00313020701684409_bib00175","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"key":"10.1080\/00313020701684409_bib00180","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.0303-6987.2004.00205.x","article-title":"Hypoxia regulation of the cell cycle in malignant melanoma: putative role for the cyclin- dependent kinase inhibitor p27","volume":"31","author":"Murphy","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1080\/00313020701684409_bib00185","first-page":"6724","article-title":"Ink4a\/arf deficiency promotes ultraviolet radiation-induced melanomagenesis","volume":"62","author":"Recio","year":"2002","journal-title":"Cancer Res"},{"key":"10.1080\/00313020701684409_bib00190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.cmr.0000134855.12474.f3","article-title":"p16INK4A expression in malignant melanomas with or without a contiguous naevus remnant: a clue to their divergent pathogenesis?","volume":"14","author":"Winnepenninckx","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1080\/00313020701684409_bib00195","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/carcin\/bgg171","article-title":"Ultraviolet A and B differently induce intracellular protein expression in human skin melanocytes\u2014a speculation of separate pathways in initiation of melanoma","volume":"24","author":"Zhang","year":"2003","journal-title":"Carcinogenesis"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516337163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516337163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T23:50:47Z","timestamp":1546473047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516337163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0031302516337163"],"URL":"https:\/\/doi.org\/10.1080\/00313020701684409","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}